Showing results (1-10 of 493) with videos related to
Sort By:
Pageof 50
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Jak/Stat pathway in Waldenström's macroglobulinemiaLucy S Hodge, Stephen M AnsellTransfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 19, 2013
Waldenström's macroglobulinemia: treatment approaches for newly diagnosed and relapsed diseaseLucy S Hodge, Stephen M AnsellBlood|December 17, 2013
Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemiaLucy S Hodge, Steven C Ziesmer, Zhi-Zhang Yang, et al.Leukemia & Lymphoma|November 12, 2013
B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cellsFrank Secreto, Michelle Manske, Tammy Price-Troska, et al.Blood|September 15, 2012
IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemiaLucy S Hodge, Steve C Ziesmer, Zhi Zhang Yang, et al.American Journal of Hematology|September 17, 2011
Annual clinical updates in hematological malignancies: a continuing medical education series. Hodgkin lymphoma: 2011 update on diagnosis, risk-stratification, and managementStephen M AnsellClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
Nivolumab in the Treatment of Hodgkin LymphomaStephen M AnsellHematology. American Society of Hematology. Education Program|December 4, 2020
Fundamentals of immunology for understanding immunotherapy for lymphomaStephen M AnsellHematology/Oncology Clinics of North America|November 30, 2013
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse)Stephen M AnsellPageof 50